TANGO THERAPEUTICS INC's ticker is and the CUSIP is 87583X109. A total of 88 filers reported holding TANGO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,027,779 | +131161.7% | 309,572 | +56.2% | 0.00% | – |
| Q1 2023 | $783 | +269.3% | 198,163 | +578.3% | 0.00% | – |
| Q4 2022 | $212 | -100.0% | 29,215 | -85.8% | 0.00% | – |
| Q3 2022 | $744,000 | +24.8% | 205,507 | +56.2% | 0.00% | – |
| Q2 2022 | $596,000 | -83.8% | 131,552 | -72.9% | 0.00% | -100.0% |
| Q1 2022 | $3,680,000 | – | 485,488 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 19,363,975 | $70,098,000 | 40.96% |
| Boxer Capital, LLC | 6,871,642 | $24,875,000 | 1.40% |
| TCG Crossover Management, LLC | 1,172,250 | $4,244,000 | 1.27% |
| Cormorant Asset Management, LP | 4,116,949 | $14,903,000 | 1.04% |
| Bain Capital Life Sciences Investors, LLC | 1,921,790 | $6,957,000 | 0.83% |
| Samsara BioCapital, LLC | 630,000 | $2,281,000 | 0.53% |
| EcoR1 Capital, LLC | 4,201,414 | $15,209,000 | 0.45% |
| Southpoint Capital Advisors LP | 4,500,000 | $16,290,000 | 0.44% |
| HARVARD MANAGEMENT CO INC | 708,385 | $2,564,000 | 0.32% |
| Avoro Capital Advisors LLC | 1,550,000 | $5,611,000 | 0.10% |